Actavia Life Sciences Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	2018 - 2014
Selling, General & Admin	0.25	0.29	0.3	0.19	0.56	0.9	Upgrade
Research & Development	0.09	0.09	0.08	0.06	-	0.01	Upgrade
Operating Expenses	0.35	4.24	0.38	0.25	0.56	0.92	Upgrade
Operating Income	-0.35	-4.24	-0.38	-0.25	-0.56	-0.92	Upgrade
Interest Expense	-0.06	-0.21	-0.94	-0.52	-0.04	-0.03	Upgrade
Currency Exchange Gain (Loss)	-	-	-	-0	0	-0	Upgrade
Other Non Operating Income (Expenses)	0	0.01	0.11	-	-	-	Upgrade
EBT Excluding Unusual Items	-0.41	-4.44	-1.21	-0.76	-0.6	-0.94	Upgrade
Impairment of Goodwill	-	-	-	-	-2.72	-	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	0.12	-	Upgrade
Asset Writedown	-	-	-	-	-2.15	-	Upgrade
Other Unusual Items	-	-	0.53	-0.11	-	-	Upgrade
Pretax Income	-0.41	-4.44	-0.69	-0.88	-5.35	-0.94	Upgrade
Income Tax Expense	-	-	-	-	-0	-0.01	Upgrade
Net Income	-0.41	-4.44	-0.69	-0.88	-5.35	-0.94	Upgrade
Net Income to Common	-0.41	-4.44	-0.69	-0.88	-5.35	-0.94	Upgrade
Shares Outstanding (Basic)	772	578	111	69	69	69	Upgrade
Shares Outstanding (Diluted)	772	578	111	69	69	69	Upgrade
Shares Change (YoY)	186.81%	418.75%	61.70%	-	-	-	Upgrade
EPS (Basic)	-0.00	-0.01	-0.01	-0.01	-0.08	-0.01	Upgrade
EPS (Diluted)	-0.00	-0.01	-0.01	-0.01	-0.08	-0.01	Upgrade
Free Cash Flow	-0.07	-0.01	-0.31	-0.29	-0.25	-0.09	Upgrade
Free Cash Flow Per Share	-	-	-0.00	-0.00	-0.00	-0.00	Upgrade
EBITDA	-	-	-0.38	-0.25	-0.55	-0.91	Upgrade
D&A For EBITDA	-	-	0	0	0	0	Upgrade
EBIT	-0.35	-4.24	-0.38	-0.25	-0.56	-0.92	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.